4//SEC Filing
McHale Duncan 4
Accession 0001694665-23-000041
CIK 0001694665other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:08 PM ET
Size
7.1 KB
Accession
0001694665-23-000041
Insider Transaction Report
Form 4
McHale Duncan
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2023-05-07+130,000→ 164,246 total - Exercise/Conversion
Restricted Stock Units
2023-05-07−130,000→ 390,000 total→ Common Stock (130,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs vest in four (4) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the first anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. These RSUs have no expiration date.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001738896
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 4:08 PM ET
- Size
- 7.1 KB